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Abstract 
Background: Pulmonary diseases affect health-related quality of life (HRQoL), but there are few data on patients’ 
adaptation to a serious illness. This study assessed resilience and its associations with HRQoL, life satisfaction, anxiety 
and depression in patients with pulmonary diseases receiving ambulatory oxygen therapy.
Methods: In this prospective cohort study, we enrolled 42 patients with pulmonary diseases receiving ambulatory 
oxygen therapy. The patients completed the following questionnaires at baseline and after one and three months; 
the Resilience Scale-25, the Life Satisfaction Scale-4, the 15D instrument of HRQoL, the Hospital Anxiety and Depres-
sion Scale (HADS) and the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0). To compare 
HRQoL, we recruited age- and gender-matched controls from the general population (n = 3574). The primary out-
come was the proportion of patients with low resilience.
Results: Half (42–48%) of the patients had low resilience, which was correlated with low HRQoL, low levels of life 
satisfaction and higher levels of anxiety and depression. Patients had very low HRQoL compared to controls. Dissatis-
faction with life increased during the 3-months follow-up, but only a few patients had anxiety or depression. Patient 
satisfaction with assistive technology was high; the median QUEST 2.0 score (scale 1–5) was 4.00 at baseline, 3.92 at 
one month and 3.88 at three months.
Conclusions: Resilience was low in half of the patients with pulmonary diseases receiving ambulatory oxygen 
therapy. Higher resilience was positively correlated with HRQoL and life satisfaction and negatively correlated with 
anxiety and depression.
Trial registration: ClinicalTrials.gov Protocol Record 507A023. Registered 17 September 2020—Retrospectively regis-
tered, https:// clini caltr ials. gov/ ct2/ resul ts? cond= & term= NCT04 55422 5& cntry= & state= & city= & dist=.
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Background
Dyspnea is a common symptom in patients with pulmo-
nary diseases, such as chronic obstructive pulmonary 
disease (COPD) [1] and interstitial lung diseases [2]. 
Patients with these diseases often have low health-related 
quality of life (HRQoL) [3, 4] and life satisfaction (LS) [5] 
and high levels of anxiety [6] and depression [5, 7, 8].
Oxygen therapy is used in patients with severe pulmo-
nary diseases to improve HRQoL [9] and prolong sur-
vival [10, 11]. Ambulatory oxygen therapy is prescribed 
to patients who become transiently hypoxemic, e.g., dur-
ing exercise or normal outdoor activities [9]. Adherence 
is an issue; Mesquita et  al. [12] found that only 46% of 
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patients with COPD were adherent to long-term oxygen 
therapy. The reasons for this low adherence include dis-
comfort related to the nasal prongs, noise and other dis-
satisfaction with the assistive device [13].
Proper adaptation to a serious illness, such as advanced 
COPD or interstitial lung diseases, necessitates resil-
ience. Resilience is the ability to appropriately adapt to 
adversities, such as health problems, traumas and other 
difficulties in life. This ability is based on a person’s psy-
chological resources, and it can be learned and improved 
with time and effort [14]. Resilience is often evaluated in 
psychological examinations and research, but less atten-
tion has been paid to resilience in the medical context 
even though resilience capacity is closely connected to 
recovery abilities and adaptation [15, 16].
To the best of our knowledge, no previous studies 
have measured resilience in patients with pulmonary 
diseases receiving ambulatory oxygen therapy and how 
it correlates with other measures of HRQoL and LS. 
In this study, we evaluated the level and correlations of 
resilience with HRQoL, LS, anxiety and depression and 
examined how satisfied patients were with ambulatory 
oxygen therapy devices and associated services. We also 
compared the HRQoL of patients with pulmonary dis-
eases receiving ambulatory oxygen therapy to an age- and 
gender-matched sample from the general population. 
The primary outcome measure was the proportion of 
patients with low resilience, and secondary outcomes 
were the correlations between resilience and HRQoL, LS, 
anxiety and depression in patients undergoing ambula-
tory oxygen therapy. Our hypothesis was that patients 
with pulmonary diseases requiring oxygen therapy would 
have low HRQoL and LS and high anxiety and depression 
at baseline and that patients with higher resilience would 
benefit more from oxygen therapy.
Methods
Study design and participants
The Research Ethics Committee of the Northern Savo 
Hospital District, Kuopio, Finland (No. 297/2017; Octo-
ber 10, 2017) approved the study protocol. The study had 
institutional approval (No. 237/2017) that was updated 
(No. 197/2018) after the new regulation of the European 
Union on the protection of natural persons with regard 
to the processing of personal data (2016/679). The study 
complies with the principles presented in the Declaration 
of Helsinki. Here, we report the first 3 months of follow-
up data from 42 patients.
This was a prospective cohort study of patients with 
pulmonary diseases receiving ambulatory oxygen ther-
apy in Finland. Patients were recruited nationwide 
across Finland between April 2018 and February 2020. 
The patients received the invitation package from the 
providers of the ambulatory oxygen device. It included 
written information about the study, a consent form, 
background questionnaires, baseline questionnaires 
and a prepaid envelope for returning the filled forms. 
The provider of the ambulatory oxygen device provided 
the invitation package only and directed any questions 
about the study to the researchers. The contact informa-
tion for the researchers was provided, and patients were 
highly encouraged to contact the researchers if they had 
anything to discuss or wanted additional information. 
Patients were eligible for the study if they were pre-
scribed ambulatory oxygen therapy because of a pulmo-
nary disease and were aged 18 years or older. We did not 
enroll patients undergoing oxygen therapy for indications 
other than pulmonary diseases.
Patients who agreed to participate in the study com-
pleted the questionnaires themselves at home at baseline 
and after one and three months. The baseline question-
naires comprised questions about background informa-
tion, and at all three time points, the patients completed 
questionnaires assessing resilience, HRQoL, LS, anxiety, 
depression and satisfaction with assistive technology. The 
second and third sets of questionnaires were mailed to 
the patients to be returned in a prepaid envelope. Those 
who had not responded within two weeks were con-
tacted and/or interviewed by phone. After the patients 
gave written consent, medical records concerning oxygen 
therapy were obtained from the hospitals that had pre-
scribed oxygen therapy.
The participants completed five questionnaires at 
each time point. The Resilience scale-25 (RS-25, [15, 17]) 
assesses resilience with 25 statements that measure sub-
jective and interpersonal protective resources that help 
in adaptation to adversities. The RS-25 is a self-report 
measure with each item scored on a 7-point Likert scale 
from 1 (strongly disagree) to 7 (strongly agree). Total 
scores range between 25 and 175: scores ranging from 
25–100 indicate very low resilience, scores from 101–115 
indicate low resilience, scores from 116–130 indicate 
moderately low resilience, scores from 131–145 indicate 
moderate resilience, scores from 146-160  indicate mod-
erately high resilience, and scores from 161–175 indicate 
high resilience. We dichotomized the resilience scores 
into two groups: scores from 25–130 indicate low resil-
ience, and scores from 131–175 indicate moderate to 
high resilience [17]. Internal consistency with the cur-
rent sample was excellent at each time point (Cronbach’s 
alpha = 0.940).
Health-related quality of life was measured by the 
15D  instrument. 15D is a generic, 15-dimensional, 
standardized, self-administered instrument that can be 
used both as a profile and a single index score measure. 
The health state descriptive system (questionnaire) is 
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composed of the following dimensions: mobility, vision, 
hearing, breathing, sleeping, eating, speech (commu-
nication), excretion, usual activities, mental function, 
discomfort and symptoms, depression, distress, vital-
ity, and sexual activity, with five levels for each dimen-
sion. The single index score (15D score), representing 
the overall HRQoL on a scale from 0 to 1 (1 = full health, 
0 = being dead), and the dimension level values, reflect-
ing the goodness of the levels relative to no problems on 
the dimension (= 1) and to being dead (= 0), are calcu-
lated from the questionnaire by using a set of population-
based preference or utility weights. Mean dimension 
level values are used to create 15D profiles for groups 
[18]. The minimum clinically important difference in 
the 15D score is ± 0.015 [19]. In the current sample, the 
internal consistency was good at each time point (Cron-
bach’s alpha = 0.859).
The HRQoL of patients was compared with that of a 
sample from the general Finnish population. The 15D 
data for the general population came from the National 
Health 2011 Health Examination Survey representing the 
Finnish population aged 18 years and older [20]. For this 
analysis, we stratified the individuals by age and gender. 
The individuals selected (n = 3574) were in the same age 
range (48–89  years) as the patients, and was matched 
with the gender distribution with the present study 
population.
The Life Satisfaction Scale-4  (LS-4, [21]) measures LS 
based on four items that measure interest and happi-
ness in life, ease of living, and loneliness. The LS-4 is a 
4-item self-report measure, and the items are scored on 
a 5-point Likert scale of decreasing LS. The total score 
varies from 4 to 20; scores ranging from 4 to 6 indicate 
that the respondent is  satisfied with life, scores from 7 
to 11 indicate that the respondent is slightly dissatisfied, 
and scores from 12 to 20 indicate that the respondent is 
dissatisfied. We dichotomized the data into two groups: 
scores from 4 to 11 indicate that the respondent is satis-
fied with life, and scores from 12 to 20 indicate that the 
respondent is dissatisfied with life. In the current sam-
ple, the internal consistency was good at each time point 
(Cronbach’s alpha = 0.841).
The Hospital Anxiety and Depression Scale (HADS, 
[22]) assesses anxiety and depressive symptoms. The 
HADS is a 14-item self-report measure with a 4-point 
scale of increasing anxiety or depression. Uneven num-
bered questions assess anxiety, and even-numbered ques-
tions assess depression. For both dimensions, scores 
of 0–7 indicate non-cases, scores of 8–10 indicate mild 
anxiety, scores of 11–14 indicate moderate anxiety, and 
scores of 15–21 indicate severe anxiety or depression. 
We dichotomized the data into two groups: scores of 
0–10 indicate no or mild symptoms, and scores of 11–21 
moderate to severe anxiety or depression. Internal con-
sistency with the current sample was excellent at each 
time point (Cronbach’s alpha = 0.912).
The Quebec User Evaluation of Satisfaction with Assis-
tive Technology 2.0 (QUEST 2.0, [23]) measures satisfac-
tion with assistive technology. QUEST 2.0 is a 12-item 
self-report measure with a 5-point Likert scale of increas-
ing satisfaction with assistive technology. The QUEST 2.0 
data are often dichotomized; scores of 1–3 indicate dis-
satisfaction, and scores of 4–5 indicate satisfaction. We 
dichotomized the data into two groups based on average 
scores: ≤ 3 indicates dissatisfaction, and > 3 indicates sat-
isfaction. Questions 1–8 assess satisfaction with assistive 
technology devices, and questions 9-12  assess satisfac-
tion with assistive technology services. For QUEST 2.0, 
we calculated the average of both sections and the total 
score. Furthermore, QUEST 2.0 has a list of 12 compo-
nents of satisfaction, from which the patient selects the 
three most important factors for them. Internal consist-
ency with the current sample was excellent at each time 
point (Cronbach’s alpha = 0.926).
Outcome measures
The primary outcome measure was the proportion of 
patients with low resilience (RS-25 ≤ 130), and the sec-
ondary outcomes were the correlations between resil-
ience and HRQoL, LS, anxiety and depression in patients 
prescribed ambulatory oxygen therapy.
Statistics
The data were entered and analyzed with SPSS software 
(IBM SPSS Statistics 25, International Business Machines 
Corporation, Armonk, NY, USA). The normality of the 
distributions of continuous variables was tested with the 
Kolmogorov–Smirnov test, the Shapiro–Wilk test and 
visual inspection of the histograms. We analyzed the con-
tinuous variables with the Wilcoxon signed-rank and the 
Friedman test, and binominal and categorical variables 
with the Cochran Q and the Chi-square test. Correlations 
between variables were evaluated with Spearman’s rank 
correlation test. Cronbach’s alpha was used to measure 
the internal consistency for each questionnaire at every 
time point. The data are presented as number of cases, 
mean (SD), median (minimum–maximum) and 95% con-
fident intervals (CI) as appropriate. P values ≤ 0.05 were 
considered statistically significant.
Results
Our aim was to collect a study sample of 100 patients 
with ambulatory oxygen therapy within 12  months, but 
due to a slow recruitment of patients and the outbreak 
of the Covid-19 pandemic, we decided to stop enrol-
ment in March 2020. Thus, we have data on 42 patients 
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at baseline, 38 patients at one month (a response rate of 
90%), and 36 patients at three months (a response rate of 
86%). Figure 1 shows the flow chart.
The patients’ baseline characteristics are shown in 
Table 1. Most patients were men (n = 32), and 28 (67%) 
had COPD. Four men had two diagnoses of pulmonary 
diseases: two of them had both COPD and pulmonary 
fibrosis; one had pulmonary fibrosis, asbestos lung dis-
ease and pleural plaques; and one had both COPD and 
asbestos. One woman had both pulmonary fibrosis and 
asthma. All patients had concomitant diseases, with car-
diovascular (n = 33) and endocrine and metabolic dis-
eases (n = 26) being the most common. Twelve patients 
had oxygen therapy before initiation of ambulatory oxy-
gen therapy and 30 patients had no previous oxygen 
therapy.
Median (minimum–maximum) scores and the dichoto-
mized data of study variables are presented in Table 2.
Low resilience was common in patients with pulmo-
nary diseases prescribed ambulatory oxygen therapy, 
and no change in resilience was observed during the 
three-month follow-up; at baseline, one month, and three 
months, 19 out of 40 (prevalence 48%; 95% CI [32, 63%], 
17/37 (46%), [30, 62%], and 15/36 patients (42%, [26, 
58%], p = 0.872) had an RS-25 score ≤ 130, respectively.
The health-related quality of life of patients with pul-
monary diseases was much worse (15D score differ-
ence < 0.035) at all time points than that of the age- and 
gender-matched sample from the general population [20] 
(p < 0.001, Fig.  2). The control group had a mean 15D 
score of 0.885 [20]; the 15D score in our sample at base-
line, one month, and three months was 0.728 (mean dif-
ference compared to the population: −  0.157, [−  0.120, 
− 0.194]), 0.714 (− 0.171, [− 0.135, − 0.207]) and 0.707 
(−  0.178, [−  0.136, −  0.220]), respectively. HRQoL had 
decreased at three months compared to the baseline, with 
Fig. 1 Flow chart of participants. RS-25 = Resilience Scale-25; LS-4 = Life Satisfaction Scale-4; 15-D = 15-D Instrument of Health-related Quality of 
Life; HADS = Hospital Anxiety and Depression Scale; QUEST 2.0 = Quebec User Evaluation of Satisfaction with Assistive Technology
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a mean difference of − 0.024 [0.002, − 0.051], (p = 0.077) 
between the baseline and three months.
Life satisfaction decreased during the three-month 
follow-up. The proportion of patients satisfied with life 
(LS-4 score from 4–11) decreased from 31 out of 42 
patients at baseline to 25 out of 38 at one month and to 
19 out of 36 patients at three months (p = 0.151).
Anxiety and depression were rather uncommon con-
sidering that the HRQoL and LS were low. At baseline, 
five patients had HADS anxiety scores ≥ 11, indicating 
moderate to high anxiety; at one month and three 
months, five patients and three patients had HADs 
scores ≥ 11, respectively (p = 0.793). For depression at 
baseline, seven patients scored ≥ 11 points, indicating 
moderate or severe depression; at one month and three 
months, five patients and four patients had high depres-
sion scores, respectively (p = 0.770).
Resilience had moderate positive correlation with 
HRQoL and QUEST 2.0 scores and negative correlation 
with anxiety, depression and LS scores, indicating that 
more resilient patients have higher LS, while those with 
less resilience have higher levels of anxiety and depres-
sion (Table  3). In a post hoc analysis, resilience did not 
correlate with age (0.076, p = 0.641) or sex (−  0.024, 
p = 0.885).
Total satisfaction with assistive technology was high; 
at baseline the median QUEST 2.0 score was 4.00, and 
at three months it was 3.88 (p = 0.687) (Table  2). The 
dichotomized scores were similar to medians: at baseline, 
five patients were dissatisfied with the assistive technol-
ogy; at one month, seven patients were dissatisfied; and at 
three months, four patients were dissatisfied (p = 0.598). 
Satisfaction with the services was higher than satisfac-
tion with the device: at baseline, the median QUEST 
2.0 score for services was 4.50 (minimum–maximum; 
1.00–5.00) vs. 3.94 for the device (1.00–5.00) (p < 0.001). 
At one month the median score was 4.25 for services 
(1.80–5.00) vs. 3.75 for the device (2.40–5.00) (p = 0.046); 
and at three months the score was 4.00 for the services 
(2.30–5.00) (p = 0.121 for repeated measurements) vs. 
3.75 for the device (2.40–5.00) (compared to services, 
p = 0.040; for repeated measurements, p = 0.836). The 
four most commonly selected satisfaction items were 
that the device was easy to use, effective, safe and its ease 
of adjustment.
Discussion
The novelty of the present study was that we evaluated 
resilience for the first time among patients with pulmo-
nary diseases receiving long-term oxygen therapy and 
examined how resilience may affect HRQoL. In our study, 
half of the patients had low resilience. This is important, 
as low resilience was associated with low HRQoL, lower 
levels of LS, and high levels of anxiety and depression. 
Our data indicate that patients starting to use ambulatory 
oxygen therapy were generally satisfied with the assistive 
technology, and satisfaction with the services was even 
higher. Taken together, these data indicate that among 
patients prescribed long-term oxygen therapy, those with 
low resilience should be identified and given psychologi-
cal support to enhance their resilience [14].
Resilience is based on a person’s psychological 
resources. However, resilience is a skill that can be 
Table 1 Baseline participant characteristics. Data are the 
number of cases or median (minimum–maximum)
BMI, body mass index; ICD-10, International Statistical Classification of Diseases 
and Related Health Problems 10th Revision
Variable All participants (N = 42)
Sex, male/female (n) 32/10
Age (years) (median (min–max)) 72 (48–89)
BMI (kg/m2) (median (min–max)) 27 (14–57)
Height (cm) (median (min–max)) 170 (149–188)
Weight (kg) (median (min–max)) 74 (47–200)
Primary pulmonary diagnosis
 COPD (n) 28
 Fibrosis (n) 12
 Asbestos lung disease and pleural plaques 
(n)
1
 Alveolar hypoventilation (n) 1
Oxygen therapy before ambulatory oxygen 
(yes/no)
12/30
Assistive technology (yes/no) 20/22
 Cane/crutches/walker (n) 18
 Wheelchair (n) 5
Comorbidities, ICD-10 group (median (min–
max))
5 (1–10)
 IX: Cardiovascular (n) 33
 IV: Endocrine and metabolic (n) 26
 X: Other respiratory (n) 19
 XIII: Musculoskeletal (n) 13
 Other (II/VI/VII/VIII/XI/XII/XIV) (n) 7/10/6/1/5/6/5
Education
 Less than high school graduate (n) 17
 High school graduate (n) 18
 More than high school (n) 7
Employed/Retired 3/39
Smoking
 Current (n) 1
 Former (n) 34
 Never (n) 7
 Smoking pack-years (median (min–max)) 30 (2–150)
Age of starting smoking (yrs.) 20 (9–34)
Mortality during the three-month follow-up 
(n)
2
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learned and improved with time and effort. Psychologi-
cal resources are required to promote successful ageing. 
Successful ageing can be described as maintaining and 
increasing good physical and mental functioning, but in 
the elderly, it also comprises LS, social functioning and 
participation. Resilience, optimism, and coping skills 
are important contributors to successful ageing despite 
physical disabilities. Subjective health is not only the 
absence of diseases [24]. Resilience can buffer the nega-
tive effects of an illness [25]. Shen et al. [26] found that 
higher resilience is associated with reduced mortality 
among the elderly, even after controlling for sociodemo-
graphic characteristics and initial health status. In sum-
mary, resilience is influenced by health status, but as it is 
modifiable, patients with low resilience should be iden-
tified and given appropriate psychological support to 
enhance their adaption to the adversity caused by pulmo-
nary diseases.
In the present study, the mean resilience score was 
between 130 and 132, which is substantially lower than 
that found in a Nordic population study of people aged 
between 60 and 90 years old (mean scores between 143–
144) [27]. Resilience scores were steady over the three-
month follow-up, which was excepted, since improving 
resilience requires time and persistence [14]. Resilience 
has been shown to be correlated with age in previous 
studies [27] but this correlation was not observed in our 
sample, presumably because of the small sample size, 
high median age and narrow age range. In a study by 
Lundman et al. [27], the covered age range was between 
19 and 103, and for every one year increase of age, the 
RS-25 score increased by 0.134 units. Future research 
should focus on discerning the level of resilience in dif-
ferent populations with pulmonary diseases and to evalu-
ate how they can effectively improve their resilience.
Consistent with published data on patients with COPD 
[3], the patients prescribed ambulatory oxygen therapy 
had a much lower HRQoL than the age- and gender-
matched sample, and based on 15D scores, HRQoL 
decreased during the three-month follow-up. This is 
assumed to indicate disease progression and its negative 
effects on HRQoL. Life satisfaction was also low, which 
is similar to previous findings [5, 28]. Similar to HRQoL, 
LS also decreased during the three-month follow-up. 
Pulmonary diseases cause dyspnea, which may further 
Table 2 Survey scores at baseline and after one and three months
RS-25, Resilience Scale-25; LS-4, Life Satisfaction Scale-4; 15D, 15-Dimensional Health-related Quality of Life (HRQoL) instrument; HADS, Hospital Anxiety and 
Depression Scale; QUEST 2.0, Quebec User Evaluation of Satisfaction with Assistive Technology (Version 2.0)





















Baseline (n = 42)
 Median (min–max) 133 (75–169) 9 (5–20) 0.748 (0.414–0.946) 5 (0–16) 5 (0–16) 4.00 (1.00–5.00)
  Dichotomizeda yes/no (n) 21/19 31/11 NA 5/37 7/35 35/5
One month (n = 38)
 Median (min–max) 132 (42–168) 9 (5–18) 0.725 (0.473–0.880) 5 (0–15) 5 (0–15) 3.92 (2.20–5.00)
  Dichotomizeda yes/no (n) 20/17 25/13 NA 5/31 5/31 32/5
Three months (n = 36)
 Median (min–max) 134 (87–164) 10 (5–20) 0.740 (0.461–0.913) 6 (0–17) 6 (0–15) 3.88 (2.70–5.00)
  Dichotomizeda yes/no (n) 21/15 19/17 NA 3/33 3/33 32/4
Fig. 2 Health-related quality of life of the population and pulmonary 
disease patients at baseline, and after one and three months. Move, 
moving; See, Seeing; Hear, Hearing; Breath, breathing; Sleep, sleeping; 
Eat, eating; Speech, speech; Excret, excretion; Uact, usual activities; 
Mental, mental function; Disco, discomfort and symptoms; Depr, 
depression; Distr, distress; Vital, vitality and Sex, sexual activity, Popul, 
age- and gender-matched control population
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decrease physical activity, deteriorate other daily activi-
ties and thus considerably worsen HRQoL and LS. A 
pulmonary disease requiring ambulatory oxygen therapy 
is at an advanced stage, and patients with these diseases 
often have several comorbidities. Thus, a decrease in 
HRQoL is expected. Satisfaction with the oxygen ther-
apy device can affect perceived HRQoL [29]. Therefore, 
appropriate information about the oxygen therapy device 
could support patients’ HRQoL. In our study, satisfac-
tion with assistive technology services was high, which 
indicates that the services were sufficient. Further long-
term studies should explore whether reinforcing resil-
ience could help to preserve or increase HRQoL in these 
patients.
The prevalence of severe anxiety (12%) and severe 
depression (17%) at baseline in our sample was two- to 
three-fold higher than that among the general popula-
tion in Finland. The annual incidence of anxiety disor-
ders in the general population in Finland is 4% and that of 
depression is 6.5% [30]. In the present study, two patients 
with anxiety at baseline did not report anxiety during 
the follow-up, while one patient developed anxiety. Two 
depressive patients at baseline did not have depressive 
symptoms after the initiation of ambulatory oxygen. Dis-
tress levels and depression measured with 15D were sub-
stantially higher in our sample compared to the general 
population, which supports the claim that patients with 
pulmonary diseases have a higher prevalence of mental 
health disorders. The size of the study sample was regret-
tably small, but as a pilot data it is assumed appropriate 
for the purpose of our analyses. Furthermore, our data 
are consistent with previous publications even with the 
inclusion of both COPD and interstitial fibrosis patients, 
indicating that anxiety and depression are common in 
this patient group [5, 28, 29, 31] and are inversely related 
to HRQoL [7, 31]. Furthermore, in a few patients with 
depressive symptoms, ambulatory oxygen therapy may 
lift their mood [29]. As a result, patients should be sys-
tematically screened for anxiety and depression when 
prescribing ambulatory oxygen therapy, and patients 
with mental health issues should be provided appropriate 
psychological support, treatment and follow-up.
There is no consensus regarding when patients should 
be prescribed ambulatory oxygen therapy. The British 
Thoracic Society [9] and Global Initiative for Chronic 
Obstructive Lung Disease (GOLD 2017) [32] recommend 
that patients with COPD having a resting stable periph-
eral capillary oxygen saturation  (SpO2) of ≤ 88–92% 
should be referred for a blood gas assessment to assess 
eligibility for long-term oxygen therapy. Furthermore, 
assessment should also be made with  SpO2 of ≤ 94% 
if patients with COPD have peripheral edema, poly-
cythemia (hematocrit ≥ 55%) or pulmonary hyperten-
sion. Many patients with pulmonary diseases, including 
COPD and interstitial fibrosis, started their long-term 
oxygen therapy with ambulatory oxygen. British Tho-
racic Society guidelines recommend that ambulatory 
oxygen therapy should be offered to patients already on 
long-term oxygen therapy who are mobile outdoors [9]. 
The 6-min walking distance (6MWD) test can discern 
whether patients with COPD with a partial pressure 
of oxygen  (PO2)  between 60 and 70  mmHg desaturate 
 (SpO2 ≤ 90%) early or late during their daily living activi-
ties. In the García-Talavera et  al. study, patients who 
desaturated after 3.5  min of the 6MWD test did not 
desaturate in the 24-h pulse oximetry, but those who 
desaturated during the first minute had a 74% probability 
of desaturating in their daily activities [33]. Even though 
the criteria are relatively clear for starting long-term 
oxygen therapy, ambulatory oxygen has been prescribed 
without proper patient assessment, counselling, support 
and follow-up. Thus, patients may use it differently than 
Table 3 Spearman correlation coefficient between resilience and other measures
15D, 15-Dimensional Health-related Quality of Life (HRQoL) instrument; LS-4, Life Satisfaction Scale-4; HADS, Hospital Anxiety and Depression Scale; QUEST 2.0, 













Baseline (n = 42)
 Spearman correlation coefficient 0.548 − 0.655 − 0.698 − 0.465 0.100
 p value < 0.001 < 0.001 < 0.001 0.002 0.546
One month (n = 38)
 Spearman correlation coefficient 0.437 − 0.410 − 0.477 − 0.468 0.276
 p value 0.007 0.012 0.003 0.004 0.104
Three months (n = 36)
 Spearman correlation coefficient 0.550 − 0.661 − 0.801 − 0.678 0.110
 p value 0.001 < 0.001 < 0.001 < 0.001 0.524
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aimed therapy, resulting in disappointments about the 
effectiveness of ambulatory oxygen therapy [34].
Limitations
Our study has some limitations. This framework solely 
pertains to patients with pulmonary diseases prescribed 
ambulatory oxygen. The major limitations of the study 
are a small sample size and different history of home oxy-
gen therapy. At baseline 12 patients were on oxygen ther-
apy and majority, 30 patients were newly starters with no 
previous oxygen therapy, and this might have introduced 
some bias in our results. Hence, this study should be con-
sidered as a pilot study of resilience in pulmonary disease 
patients receiving ambulatory oxygen therapy. Further 
long-term studies should be conducted measuring resil-
ience and HRQoL in different pulmonary diseases and 
different history of long-term oxygen therapy use. Due 
to 30 patients being new starters with no previous oxy-
gen therapy, our sample might be less morbid than the 
average patients with pulmonary diseases receiving long-
term oxygen therapy.
Second, all patients had comorbidities, and cardiovas-
cular diseases were the most common. In our data, it is 
impossible to distinguish the impact of pulmonary dis-
eases and other health issues on participants’ HRQoL 
and other parameters measured in the present study. 
Third, missing information existed in excess about 
patients’ physical performance, level of hypoxemia and 
hours of oxygen therapy used per day; therefore, we 
could not include them in our analyses. One of the main 
limitations was a small sample size, but difficulties in 
enrolling patients have also been common in other stud-
ies. Our aim was to enroll 100 patients, but due to low 
response rates that are common in pulmonary disease 
patients [35] and the outbreak of COVID-19, we decided 
to stop enrolling in March 2020. Finally, we used self-
administered questionnaires and the interpretation of 
survey questions and rating scales can vary between indi-
viduals. Nonetheless, we used commonly used, validated 
questionnaires with closed-end questions that are easier 
to recall for the respondents than open-end questions. 
Moreover, self-administered questionnaires are less likely 
to interviewer bias in this kind of studies where sensi-
tive issues are evaluated. Our study consisted of three 
repeated measurements, and adherence was high, thus 
decreasing the likelihood of compliance bias and sup-
porting that our data is soundly based.
Conclusions
In our data resilience was low in half of the patients with 
pulmonary diseases undergoing ambulatory oxygen 
therapy and HRQoL of these patients was much worse 
than that of the general population. This is important 
knowledge, as higher resilience was positively correlated 
with HRQoL and LS, and negatively correlated with anxi-
ety and depression. Patients with low resilience should 
be identified and given psychological support to enhance 
their resilience, thus helping them to better adapt to 
adversity.
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